ESCROW AGREEMENTEscrow Agreement • August 31st, 2021 • Genetic Technologies LTD • Biological products, (no disgnostic substances) • New York
THIS ESCROW AGREEMENT (this “Agreement”) is made and entered into as of August 12, 2021, by and among Genetic Technologies Limited, a company formed under the laws of the Commonwealth of Australia ( “Buyer”), General Genetics Corporation, a Delaware corporation (“Seller Party Representative” and, together with Buyer, sometimes referred to individually as a “Party” and collectively as the “Parties”), and Citibank, N.A., as escrow agent (the “Escrow Agent”).
NON-SOLICITATION AGREEMENTNon-Solicitation Agreement • August 31st, 2021 • Genetic Technologies LTD • Biological products, (no disgnostic substances)
This NON-SOLICITATION AGREEMENT (this “Agreement”) is entered into as of 18 July 2021, by and between Genetic Technologies Limited, a company formed under the laws of the Commonwealth of Australia (“Buyer”), and BelHealth Investment Fund II, L.P., a Delaware limited partnership (the “Restricted Party”). Each of Buyer and the Restricted Party is sometimes referred to herein individually as a “Party” and collectively as the “Parties”. Capitalized terms used herein without being otherwise defined shall have the meanings assigned thereto in the Purchase Agreement (defined below).
SALE OF BUSINESS AGREEMENTSale of Business Agreement • August 31st, 2021 • Genetic Technologies LTD • Biological products, (no disgnostic substances) • Victoria
Genetic Technologies Limited ACN 009 212 328, a company formed under the laws of the Commonwealth of Australia, with its principal office at 60-66 Hanover Street, Fitzroy, Victoria 3065 Australia
REGISTRATION RIGHTS AGREEMENT REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 31st, 2021 • Genetic Technologies LTD • Biological products, (no disgnostic substances) • New York
THIS REGISTRATION RIGHTS AGREEMENT is made as of the 12th day of August, 2021, by and among Genetic Technologies Limited, a company formed under the laws of the Commonwealth of Australia (the “Company”), and each of General Genetics Corporation, General Genetics Europe Limited, General Genetics Limited UK and Genetic Test Laboratories Australia Pty Limited (each, an “Investor” and together, the “Investors”).
